Markets Gone Wild

Pomerantz LLP Announces Class Action Lawsuit Against Caribou Biosciences, Inc. Overview On December 30, 2024, Pomerantz LLP announced that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) and certain officers. The class action, filed in the United States District Court for the Northern District of California,…

Nebius (NBIS) Expands Facilities to Meet the Insatiable Demand for Artificial Intelligence In today’s rapidly evolving technological landscape, the demand for artificial intelligence (AI) solutions continues to soar. One company, Nebius (NBIS), is answering the call by expanding its existing facilities and building new ones to capitalize on this insatiable demand. Expanding Existing Facilities Nebius’s…

Exploring the Large Cap Value Segment of the US Equity Market: A Closer Look at the First Trust Morningstar Dividend Leaders ETF (FDL) If you’re an investor seeking broad exposure to the Large Cap Value segment of the US equity market, you might want to consider adding the First Trust Morningstar Dividend Leaders ETF (FDL)…

VolitionRx to Present at the International Symposium on Intensive Care & Emergency Medicine in Brussels VolitionRx Limited, a leading epigenetics company, has recently announced its participation in the 44th Annual International Symposium on Intensive Care & Emergency Medicine (ISICEM) in Brussels, Belgium. The congress is scheduled to take place from March 18-21, 2025. Volition’s Role…

DraftKings CEO Jason Robins Discusses the Rise of Betting Rivals Outside of Gaming Introduction In a recent appearance on “Bloomberg Technology,” DraftKings CEO Jason Robins detailed the rise of betting rivals outside of gaming as he prepares for one of the biggest betting days ever on Super Bowl Sunday. Robins joined hosts Caroline Hyde and…